# Innoviva, Inc.: Form SCHEDULE 13D/A, filed Mar 7, 2025

- Company: [Innoviva, Inc.](/companies/inva.md) (CIK 1080014)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-07
- Accepted by EDGAR: Mar 7, 2025, 21:30 ET
- Period: not reported
- Accession: 0000899140-25-000411
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1080014/000089914025000411/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1080014/000089914025000411/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1080014/000089914025000411/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000899140-25-000411. Last ingested by Listed: Nov 4, 2026, 17:42 ET. No prices; not investment advice.